Alex Frew McMillan
As a free-lancer, he has written regularly for The New York Times, and is a contributor to TheStreet.com and Forbes. He has also written the occasional piece for publications such as The Wall Street Journal, the Financial Times, The Australian, the Economist Intelligence Unit and CNBC.
He covered the September 11, 2001 attacks for CNN, writing the first reaction to the disaster from governments around the world, and wrote a series of well-regarded stories about greater China’s property slowdown for Reuters. His real-estate coverage has explained the importance of property trends for institutional investors as well as for individual property owners. He also covered the hedge-fund industry for six years and has focused on alternative as well as personal finance.
Since moving to Hong Kong from New York City 15 years ago, he has devoted himself to coverage of Asia, writing magazine stories and analysis pieces for Asian Investor, the South China Morning Post and the Straits Times, as well as many magazines. He has also made numerous appearances on both television and radio to discuss his work.
With a South African father and British mother, he took up a Morehead Scholarship to study in the United States, one of the best-known merit scholarships in the country, offered to candidates considered to have leadership potential.
He graduated with a degree in Journalism and English from the University of North Carolina at Chapel Hill, with honors and distinction, and serves as co-chairman of the university's alumni association in Hong Kong. Besides reporting, he is also an avid tennis player, snowboarder and scuba diver, and is a PADI-certified divemaster.
Recent Articles By The Author
Nomura, Credit Suisse warn profits will take a hit after a client - reportedly Archegos Capital Management - missed margin payments.
Sudden internet anger over months-old comments about Xinjiang cotton benefits Chinese apparel makers.
Lies, damn lies, and statistics in the vaccine age, as Hong Kong and Macau stop administering the Pfizer/BioNTech drug.
Despite a damning report that Crown shouldn't get a license for a new casino in Sydney, BX wants to buy them for A$8 billion.
Toshiba has fallen on hard times. Will top executives fall on their sword now that shareholders are running the show?
This comes immediately prior to the first high-level meeting between U.S. and Chinese officials.
Hong Kong activists want Europe's parliament to vote down a trade deal rushed through before Biden took office.
With flight crews spending a couple weeks in quarantine each time they fly, the airline holds out hope the Chinese "vaccine passport" experiment works.
The index of major Chinese technology companies listed in Hong Kong has given up 20.5% of its value in less than a month.